Frederick Feit, MD

  • Specialties: Interventional Cardiology, Cardiology
  • Language: English
  • Phone: 212-263-5656

About Me

Conditions and Treatments

mitral valve disease, mitral regurgitation (MR), atrial septal defect (ASD), acute coronary syndrome, heart attack, pulmonary stenosis, aortic valve disease, renal artery stenosis, peripheral vascular disease (PVD), mitral valve stenosis, carotid artery disease, aortic valve stenosis, heart valve diseases, claudication, aortic valve insufficiency, arterial occlusive disease, peripheral vascular disease (PVD), critical limb ischemia, carotid stenosis, cardiac catheterization
Show More Conditions

Credentials

Positions

  • Associate Professor, Department of Medicine
  • Dir Card Cath & Interventional Card BV

Board Certifications

    1999
  • American Board of Internal Medicine (Interventional Cardiology)
    1979
  • American Board of Internal Medicine (Cardiovascular Disease)
    1976
  • American Board of Internal Medicine - Internal Medicine

Education and Training

  • 1978
  • Fellowship, NYU Medical Center, Cardiology
  • 1976
  • Residency, NYU Medical Center
  • 1972
  • MD from New York University

Departments

Locations and Appointments

65 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Cigna EPO/POS
  • Cigna PPO
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield Healthy NY
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicaid
  • Fidelis Medicare
  • GHI CBP
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Family Health
  • HIP HMO
  • HIP Medicaid
  • HIP Medicare
  • HIP POS
  • HealthPlus Child Health (Amerigroup)
  • HealthPlus Family Health (Amerigroup)
  • HealthPlus Medicaid (Amerigroup)
  • HealthRepublic
  • HealthSmart (WTC)
  • Humana Medicare
  • Local 1199 PPO
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • NYS Empire Plan
  • Oscar
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • Tricare
  • United Exchange- Compass
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.

NYU Cardiac Catheterization Associates
550 1st Avenue, 14th Floor
New York, NY 10016

Contact

Phone: 212-263-5656

Cardiac Catheterization Laboratory

Contact

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Angiography and Restenosis

In addition to performing over 2,000 of diagnostic angiography catheterizations, over 500 angioplasties are performed annually at NYU Medical Center. Balloon angioplasty is sometimes followed by restenosis.

Frederick Feit M.D.'s studies are focused on this persistent clinical problem which affects approximately 30 percent of patients within 6 months. Second angioplasties and/or bypass surgeries are the common follow-up procedure to correct restenosis. New procedures such as atherectomy, and implantation of a stent are also being investigated in this laboratory. The long term effectiveness of atherectomy and stents is, however, unknown and far more research in this area needs to be conducted.

Research is underway into the biological basis for restenosis, which is partially due to a biological response or an attempt at healing the damage to the artery that is mediated by growth factors. The blocking of growth factors or genes that stimulate restinosis factors constitute some of the directions of future research, conducted in collaboration with the Medical Center's basic scientists.

Publications

  • Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: Insight from over 8.1 million percutaneous coronary interventions

    Bangalore, Sripal; Gupta, Navdeep; Genereux, Philippe; Guo, Yu; Pancholy, Samir; Feit, Frederick 2015 Jan; 6-10, International journal of cardiology — id: 1462382, year: 2015, page: 6, stat: JOURNAL ARTICLE
  • Trend in the use of drug eluting stents in the United States: Insight from over 8.1million coronary interventions

    Bangalore, Sripal; Gupta, Navdeep; Guo, Yu; Feit, Frederick 2014 May; 336-337, International journal of cardiology — id: 1013442, year: 2014, page: 336, stat: JOURNAL ARTICLE
  • Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials

    Bangalore, Sripal; Singh, Amita; Toklu, Bora; DiNicolantonio, James J; Croce, Kevin; Feit, Frederick; Bhatt, Deepak L 2014; e000068-e000068, Open heart — id: 1315392, year: 2014, page: e000068, stat: Journal Article
Read All Publications (188)